Intestinal peptide and protein delivery: Novel bioadhesive drug-carrier matrix shielding from enzymatic attack

Journal of Pharmaceutical Sciences

Volumn 87, Issue 4, 1998, Pages 430-434

  Bernkop Schnürch, Andreas ^a   Pasta, Martina ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVE AGENT; BOWMAN BIRK INHIBITOR; CARBOXYPEPTIDASE A; CHITOSAN; CHYMOTRYPSIN; DRUG; DRUG CARRIER; EDETIC ACID; ELASTASE; INTESTINE ENZYME; MICROSOMAL AMINOPEPTIDASE; PEPTIDE; POLYMER; PROTEIN; TRYPSIN; ZINC;

ARTICLE; BINDING AFFINITY; CONJUGATE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; IN VITRO STUDY;

EID: 0031901490     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js970410u     Document Type: Article

References (24)

1. Fujii, S.; Yokoyama, T.; Ikegaya, K.; Sato, F.; Yokoo, N. Promoting effect of the new chymotrypsin inhibitor FK-448 on the intestinal absorption of insulin in rats and dogs. J. Pharm. Pharmacol. 1985, 37, 545-549.
2. Langguth, P.; Merkle, H. P.; Amidon, G. L. Oral absorption of peptides: The effect of absorption site and enzyme inhibition on the systemic availability of metkephamid. Pharm. Res. 1994, 11, 528-535.
3. Yamamoto, A.; Taniguchi, T.; Rikyuu, K.; Tsuji, T.; Fujita, T.; Murakami, M.; Muranishi, S. Effects of Various Protease Inhibitors on the Intestinal Absorption and Degradation of Insulin in Rats. Pharm. Res. 1994, 11, 1496-1500.
4. Morishita, I.; Morishita, M.; Takayama, K.; Machida, Y.; Nagai, T. Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats. Int. J. Pharm. 1992, 78, 9-16.
5. Woodley, J. F. Enzymatic Barriers for GI Peptide and Protein Delivery. Crit Rev. Ther. Drug 1994, 11, 61-95.
6. Melmed, R. N.; El-Aaser, A. A.; Holt, S. J. Hypertrophy and hyperplasia of the neonatal rat exocrine pancreas induced by orally administered soy bean trypsin inhibitor. Biochim. Biophys. Acta 1976, 421, 280-288.
7. McGuinness, E. E.; Hopwood, D.; Wormsley, K. G. Further studies of the effects of raw soya flour on the rat pancreas. Scand. J. Gastroenterol. 1982, 17, 273-277.
8. Ge, Y. C.; Morgan, R. G. H. The effect of trypsin inhibitor on the pancreas and small intestine of mice. Br. J. Nutr. 1993, 70, 333-345.
9. Bernkop-Schnürch, A.; Bratengeyer, I.; Valenta, C. Development and in vitro evaluation of a drug delivery system protecting from trypsinic degradation. Int. J. Pharm. 1997, 157, 17-25.
10. Bernkop-Schnürch, A.; Göckel, N. C. Development and analysis of a polymer protecting from luminal enzymatic degradation caused by α-chymotrypsin. Drug Dev. Ind. Pharm. 1997, 23, 733-740.
11. Bernkop-Schnürch, A.; Dundalek, K. Novel bioadhesive drug delivery system protecting (poly)peptides from gastric enzymatic degradation. Int. J. Pharm. 1996, 138, 75-83.
12. Reseland, J. E.; Holm, H.; Jacobsen, M. B.; Jenssen, T. G.; Hanssen, L. E. Proteinase Inhibitors Induce Selective Stimulation of Human Trypsin and Chymotrypsin Secretion. Hum. Clin. Nutr. 1996, 126, 634-642.
13. Bernkop-Schnürch, A.; Krajicek, M. E. Mucoadhesive polymers for peroral peptide delivery: synthesis and evaluation of chitosan-EDTA conjugates. J. Controlled Release 1997, in press.
14. Bernkop-Schnürch, A.; Apprich, I. Synthesis and evaluation of a modified mucoadhesive polymer protecting from α-chymotrypsinic degradation. Int. J. Pharm. 1997, 146, 247-254.
15. Junginger, H. E. Bioadhesive polymer systems for peptide delivery. Acta Pharm. Technol. 1990, 36, 110-126.
16. Birk, Y. The Bowman-Birk inhibitor. Int. J. Pept. Protein Res. 1985, 25, 113-131.
17. Bernkop-Schnürch, A.; Schwarz, G. H.; Kratzel, M. Modified Mucoadhesive Polymers for the Peroral Administration of Mainly Elastase Degradable Therapeutic (Poly)peptides. J. Controlled Release. 1997, 47, 113-121.
18. Bernkop-Schnürch, A.; Paikl, Ch.; Valenta, C. Novel Bioadhesive Chitosan-EDTA Conjugate Protects Leucine Enkephalin from Degradation by Aminopeptidase N. Pharm. Res. 1997, 14, 917-922.
19. Lehr, C.-M. Bioadhesion Technologies for the Delivery of Peptide and Protein Drugs to the Gastrointestinal Tract. Crit. Rev. Ther. Drug 1994, 11, 119-160.
20. Bernkop-Schnürch, A.; Marschütz, M. Development and in vitro evaluation of systems to protect peptide drugs from aminopeptidase N. Pharm. Res. 1997, 14, 181-185.
21. Luessen, H. L.; Bohner, V.; Pérard, D.; Langguth, P.; Verhoef, J. C.; de Boer, A. G.; Merkle, H. P.; Junginger, H. E. Mucoadhesive polymers in peroral peptide drug delivery. V. Effect of poly(acrylates) on the enzymatic degradation of peptide drugs by intestinal brush border membrane vesicles. Int. J. Pharm. 1996, 141, 39-52.
22. Lindahl, A.; Ungell, A.-L.; Knutson, L.; Lennernäs, H. Characterization of Fluids from the Stomach and Proximal Jejunum in Men and Women. Pharm. Res. 1997, 14, 497-502.
23. Valenta, C.; Christen, B.; Bernkop-Schnürch, A. Chitosan-EDTA conjugate: A novel polymer for topical used gels. Farmacevtski Vestnik 1997, 48, 354-355.
24. 2EDTA, and Aprotinin on Rectal, Nasal, and Buccal Insulin Delivery. Pharm. Res. 1988, 5, 305-308.